Henkel AG & Co. KGaA
Henkel AG & Co. KGaA (HEN3.F) Financial Performance & Income Statement Overview
Explore the financials of Henkel AG & Co. KGaA (HEN3.F), including yearly and quarterly data on income, cash flow, and balance sheets.
Henkel AG & Co. KGaA (HEN3.F) Income Statement & Financial Overview
Review Henkel AG & Co. KGaA HEN3.F income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $10.77B | $10.81B | $10.59B | $5.46B |
Cost of Revenue | $5.43B | $5.34B | $5.63B | $3.02B |
Gross Profit | $5.34B | $5.48B | $4.96B | $2.44B |
Gross Profit Ratio | $0.50 | $0.51 | $0.47 | $0.45 |
R&D Expenses | $331.00M | $303.00M | $302.00M | $142.50M |
SG&A Expenses | $3.75B | $3.56B | $3.43B | $1.68B |
Operating Expenses | $4.13B | $3.86B | $3.88B | $2.02B |
Total Costs & Expenses | $9.56B | $9.20B | $9.51B | $1.004B |
Interest Income | $48.00M | $53.00M | $49.00M | $24.00M |
Interest Expense | $161.00M | $55.00M | $49.00M | $16.50M |
Depreciation & Amortization | $417.00M | $409.00M | $229.00M | $421.00M |
EBITDA | $1.65B | $2.03B | $1.68B | $753.50M |
EBITDA Ratio | $0.15 | $0.19 | $0.16 | $0.14 |
Operating Income | $1.21B | $1.62B | $1.45B | $616.50M |
Operating Income Ratio | $0.11 | $0.15 | $0.14 | $0.11 |
Other Income/Expenses (Net) | $94.00M | -$202.00M | -$370.00M | -$211.00M |
Income Before Tax | $1.31B | $1.42B | $1.08B | $405.50M |
Income Before Tax Ratio | $0.12 | $0.13 | $0.10 | $0.07 |
Income Tax Expense | $317.00M | $374.00M | $312.00M | $118.50M |
Net Income | $977.00M | $1.03B | $754.00M | $282.00M |
Net Income Ratio | $0.09 | $0.10 | $0.07 | $0.05 |
EPS | $2.32 | $2.46 | $1.80 | $0.67 |
Diluted EPS | $2.32 | $2.46 | $1.80 | $0.67 |
Weighted Avg Shares Outstanding | $419.87M | $419.35M | $419.28M | $420.16M |
Weighted Avg Shares Outstanding (Diluted) | $419.87M | $419.35M | $419.28M | $420.16M |
The company's financials show resilient growth, with revenue advancing from $5.46B in Q2 2023 to $10.77B in Q4 2024. Gross profit remained healthy with margins at 50% in Q4 2024 compared to 45% in Q2 2023. Operating income hit $1.21B last quarter, sustaining a consistent 11% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.65B. Net income dropped to $977.00M, while earnings per share reached $2.32. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan